These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 29596815

  • 1. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
    Verhoven SM, Groszek JJ, Fissell WH, Seegmiller A, Colby J, Patel P, Verstraete A, Shotwell M.
    Clin Chim Acta; 2018 Jul; 482():60-64. PubMed ID: 29596815
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
    Connor MJ, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH.
    Antimicrob Agents Chemother; 2011 Feb; 55(2):557-60. PubMed ID: 21115798
    [Abstract] [Full Text] [Related]

  • 3. A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.
    Veillette JJ, Winans SA, Forland SC, Maskiewicz VK.
    J Pharm Biomed Anal; 2016 Nov 30; 131():80-86. PubMed ID: 27529601
    [Abstract] [Full Text] [Related]

  • 4. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
    Lheureux O, Trepo E, Hites M, Cotton F, Wolff F, Surin R, Creteur J, Vincent JL, Gustot T, Jacobs F, Taccone FS.
    Liver Int; 2016 Jul 30; 36(7):1002-10. PubMed ID: 26645828
    [Abstract] [Full Text] [Related]

  • 5. A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
    Popowicz ND, O'Halloran SJ, Fitzgerald D, Lee YCG, Joyce DA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr 01; 1081-1082():58-66. PubMed ID: 29505960
    [Abstract] [Full Text] [Related]

  • 6. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
    Marselos SC, Archontaki HA.
    J Pharm Biomed Anal; 2002 Jul 31; 29(5):787-93. PubMed ID: 12093510
    [Abstract] [Full Text] [Related]

  • 7. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
    Arzuaga A, Isla A, Gascón AR, Maynar J, Martín A, Solinís MA, Toral D, Pedraz JL.
    Biomed Chromatogr; 2005 Oct 31; 19(8):570-8. PubMed ID: 15828066
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM, Jarrett P, Boots RJ, Kirkpatrick CM, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2014 Apr 31; 43(4):343-8. PubMed ID: 24612982
    [Abstract] [Full Text] [Related]

  • 9. New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.
    Trittler R, Ehrlich M, Galla TJ, Horch RE, Kümmerer K.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug 05; 775(2):127-32. PubMed ID: 12113978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    Sörgel F, Kinzig M.
    J Antimicrob Chemother; 1993 Jan 05; 31 Suppl A():39-60. PubMed ID: 8383655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
    Jung B, Mahul M, Breilh D, Legeron R, Signe J, Jean-Pierre H, Uhlemann AC, Molinari N, Jaber S.
    Crit Care Med; 2017 May 05; 45(5):e470-e478. PubMed ID: 28240688
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam.
    Martínková J, Malbrain ML, Havel E, Šafránek P, Bezouška J, Kaška M.
    Anaesthesiol Intensive Ther; 2016 May 05; 48(1):23-8. PubMed ID: 26588478
    [Abstract] [Full Text] [Related]

  • 19. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    Tomaselli F, Dittrich P, Maier A, Woltsche M, Matzi V, Pinter J, Nuhsbaumer S, Pinter H, Smolle J, Smolle-Jüttner FM.
    Br J Clin Pharmacol; 2003 Jun 05; 55(6):620-4. PubMed ID: 12814459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.